Physician profile
Monica Perlman
NPI 1780796235
$22,523.00
in general payments reported to CMS, 2019-2025
87 companies · $4,204 in 2025
The $4,204 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,191 · 2020: $2,306 · 2021: $2,431 · 2022: $5,506 · 2023: $2,728 · 2024: $3,155 · 2025: $4,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,588 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,587.74 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $2,118.22 | 2022 | |
| Amgen INC. | $1,888.13 | 2019-2025 | Repatha, Otezla, Evenity |
| Eli Lilly and Company | $1,500.00 | 2025 | |
| Abbvie INC. | $1,396.40 | 2019-2025 | |
| Abbott Laboratories | $1,187.87 | 2020-2025 | Octrode, Aveir |
| Astrazeneca Pharmaceuticals LP | $1,182.01 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novartis Pharmaceuticals Corporation | $1,125.16 | 2019-2025 | |
| Glaxosmithkline, LLC. | $953.43 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $706.11 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $656.38 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Merz North America, INC. | $541.56 | 2019-2022 | |
| Hologic Sales and Service, LLC | $517.29 | 2019-2025 | Aptima |
| Genzyme Corporation | $467.19 | 2023-2025 | |
| Radius Health, INC. | $461.98 | 2020-2021 | |
| Si-Bone, INC. | $403.04 | 2020-2022 |
Show all 87 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $388.88 | 2025 | |
| Pfizer INC. | $337.39 | 2019-2025 | |
| Gilead Sciences, INC. | $329.13 | 2019-2023 | |
| Neuronetics, INC. | $301.28 | 2022 | |
| Sanofi-Aventis U.S. LLC | $288.89 | 2019-2025 | |
| Boston Scientific Corporation | $281.72 | 2020-2024 | Watchman Flx |
| Heartflow, INC. | $266.17 | 2024-2025 | |
| Dexcom, INC. | $256.00 | 2021-2024 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Bayer Healthcare Pharmaceuticals INC. | $239.35 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $237.25 | 2019-2025 | Austedo Xr |
| Inspire Medical Systems, INC. | $221.46 | 2024-2025 | Inspire |
| Phadia US INC. | $218.67 | 2023-2025 | Immunocap |
| Medtronic, INC. | $215.94 | 2021-2024 | Linq II |
| Janssen Pharmaceuticals, INC | $195.19 | 2019-2025 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $190.85 | 2019-2025 | Xifaxan |
| Cleerly, INC. | $187.34 | 2024-2025 | Cleerly Labs, Cleerly Ischemia |
| Phathom Pharmaceuticals, INC. | $184.48 | 2024-2025 | Voquezna |
| Eisai INC. | $184.44 | 2020 | |
| Daiichi Sankyo INC. | $183.35 | 2019-2020 | |
| Sanofi Pasteur INC. | $180.82 | 2019-2022 | |
| Therapeuticsmd, INC. | $170.76 | 2019-2021 | |
| Stryker Corporation | $165.27 | 2023 | Clarifix Cryotherapy Device |
| Philips North America LLC | $151.57 | 2022-2025 | (Ck7) Extended Holter, (Ck4) Mcot, Extended Holter |
| Allergan, INC. | $117.72 | 2019-2020 | |
| Ibsa Pharma INC. | $117.44 | 2019-2021 | |
| Neurent Medical Limited | $114.63 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Takeda Pharmaceuticals U.S.A., INC. | $107.41 | 2019 | |
| Neurelis, INC. | $100.27 | 2023 | Valtoco |
| Esperion Therapeutics, INC. | $94.78 | 2023-2025 | Nexletol |
| Myriad Women'S Health, INC. | $83.99 | 2023 | Myrisk |
| Baxter Healthcare | $79.63 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Cardioperfect |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.78 | 2022-2025 | Jardiance, Ofev |
| Exact Sciences Corporation | $71.00 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $66.91 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $66.85 | 2019 | |
| Tms Neurohealth Centers INC. | $59.77 | 2025 | Tms Neurohealth Centers INC. |
| Itamar Medical INC | $54.03 | 2022-2025 | Watchpatone |
| Merck Sharp & Dohme LLC | $53.09 | 2019-2022 | |
| Bausch Health US, LLC | $43.57 | 2022 | |
| Astellas Pharma US INC | $43.56 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $40.48 | 2023 | Givlaari |
| Viiv Healthcare Company | $38.89 | 2024 | Apretude |
| Harmony Biosciences LLC | $36.65 | 2024 | |
| Linus Health, INC. | $35.60 | 2022 | |
| Qorumpartners | $34.35 | 2022 | |
| Revance Therapeutics, INC. | $30.96 | 2024 | Daxxify |
| Otsuka America Pharmaceutical, INC. | $28.37 | 2024 | Rexulti |
| Incyte Corporation | $27.12 | 2025 | Opzelura |
| Medline Industries LP | $26.69 | 2023 | |
| Genentech USA, INC. | $24.76 | 2020 | |
| Corcept Therapeutics | $24.68 | 2025 | Korlym |
| Lundbeck LLC | $22.90 | 2022 | |
| Irhythm Technologies, INC. | $21.30 | 2024 | Zio Monitor, Zio Xt Patch |
| Biofrontera INC. | $19.46 | 2020 | |
| Optinose US, INC. | $19.42 | 2024 | |
| Grifols USA, LLC | $19.11 | 2024 | Prolastin-C Liquid |
| Topcon Healthcare Solutions, INC. | $18.09 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.46 | 2022 | |
| Exeltis, USA INC. | $16.83 | 2020 | |
| Iroko Pharmaceuticals, LLC | $16.82 | 2019 | |
| Tactile Systems Technology INC | $16.59 | 2021 | |
| Seqirus USA INC | $16.05 | 2022 | |
| Xeris Pharmaceuticals, INC. | $15.64 | 2022 | |
| Medtronic Vascular, INC. | $15.56 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.06 | 2019 | |
| Avion Pharmaceuticals | $13.87 | 2023 | Methylphenidate Hydrochloride |
| Sonex Health, INC. | $13.73 | 2025 | Sx-One Microknife |
| Sumitomo Pharma America, INC. | $13.72 | 2025 | Gemtesa |
| Mayne Pharma Commercial LLC | $13.45 | 2025 | |
| Biogen, INC. | $12.65 | 2021 | |
| Assertio Therapeutics, INC. | $12.64 | 2020 | |
| Axsome Therapeutics, INC. | $10.70 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Perlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.